Works matching IS 10073639 AND DT 2022 AND VI 32 AND IP 5
Results: 11
儿童及青少年分化型甲状腺癌核医学诊治中国 专家共识（2022年版）.
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 451, doi. 10.19401/j.cnki.1007-3639.2022.05.011
- Publication type:
- Article
BRAF V600突变阳性的晚期黑色素瘤治疗的 临床研究进展.
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 445, doi. 10.19401/j.cnki.1007-3639.2022.05.010
- By:
- Publication type:
- Article
T-G-C纳米材料联合声动力学治疗喉癌的研究.
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 436, doi. 10.19401/j.cnki.1007-3639.2022.05.009
- By:
- Publication type:
- Article
早期左侧乳腺癌保乳术后大分割放疗同期瘤床 加量的安全性及心脏亚结构剂量评估的重要性 研究
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 427, doi. 10.19401/j.cnki.1007-3639.2022.05.008
- By:
- Publication type:
- Article
HER2阳性浸润性乳腺癌新辅助治疗反应的预测 因子及治疗前后HER2状态变化的评估
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 417, doi. 10.19401/j.cnki.1007-3639.2022.05.007
- By:
- Publication type:
- Article
可疑甲状腺球蛋白增高性分化型甲状腺癌患者 经<sup>131</sup>I治疗后的临床转归.
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 410, doi. 10.19401/j.cnki.1007-3639.2022.05.006
- By:
- Publication type:
- Article
不同年龄儿童及青少年分化型甲状腺癌患者的 临床病理学特征与<sup>131</sup>I治疗分析
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 405, doi. 10.19401/j.cnki.1007-3639.2022.05.005
- By:
- Publication type:
- Article
儿童及青少年甲状腺结节分级诊断模型的 建立与验证.
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 397, doi. 10.19401/j.cnki.1007-3639.2022.05.004
- By:
- Publication type:
- Article
基因突变特征与儿童及青少年分化型甲状腺癌 远处转移相关性的meta分析.
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 388, doi. 10.19401/j.cnki.1007-3639.2022.05.003
- By:
- Publication type:
- Article
局部晚期或转移性儿童及青少年分化型甲状腺癌的 基因特征与临床特征及<sup>131</sup>I疗效的关系
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 381, doi. 10.19401/j.cnki.1007-3639.2022.05.002
- By:
- Publication type:
- Article
转移性儿童甲状腺癌的遗传学特征和预后.
- Published in:
- China Oncology, 2022, v. 32, n. 5, p. 373, doi. 10.19401/j.cnki.1007-3639.2022.05.001
- By:
- Publication type:
- Article